Ftse Mib
34.824,46
0,18%
DAX
18.843,36
0,44%
S&P 500
5.304,72
0,70%
NASDAQ
16.920,79
1,10%
Bitcoin
68.081,99
-1,89%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ TRACON Pharmaceuticals Inc (TCON) TRACON Pharmaceuticals Inc (TCON) Notizie

TCON

TRACON Pharmaceuticals (TCON)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:TCON
DataOraFonteTitoloSimboloCompagnia
14/05/202423:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TCONTRACON Pharmaceuticals Inc
14/05/202422:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCONTRACON Pharmaceuticals Inc
13/05/202423:00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TCONTRACON Pharmaceuticals Inc
07/03/202423:03Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TCONTRACON Pharmaceuticals Inc
05/03/202423:00Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:TCONTRACON Pharmaceuticals Inc
28/02/202422:02GlobeNewswire Inc.TRACON to Report Fourth Quarter and Year-End 2023 Financial Results and Provide Corporate Update on March 5, 2024NASDAQ:TCONTRACON Pharmaceuticals Inc
14/02/202422:31Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TCONTRACON Pharmaceuticals Inc
09/02/202422:05Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:TCONTRACON Pharmaceuticals Inc
07/08/202323:02Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:TCONTRACON Pharmaceuticals Inc
25/07/202323:19Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:TCONTRACON Pharmaceuticals Inc
20/06/202314:09Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TCONTRACON Pharmaceuticals Inc
02/06/202322:47Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:TCONTRACON Pharmaceuticals Inc
01/06/202312:06Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:TCONTRACON Pharmaceuticals Inc
31/05/202322:22Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:TCONTRACON Pharmaceuticals Inc
19/05/202323:02Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:TCONTRACON Pharmaceuticals Inc
03/05/202322:02GlobeNewswire Inc.TRACON to Report First Quarter 2023 Financial Results and Provide Corporate Update on May 10, 2023NASDAQ:TCONTRACON Pharmaceuticals Inc
28/04/202312:23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TCONTRACON Pharmaceuticals Inc
06/04/202314:30GlobeNewswire Inc.Runway Growth Finance Corp. Provides First Quarter 2023 Portfolio UpdateNASDAQ:TCONTRACON Pharmaceuticals Inc
16/03/202311:02Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:TCONTRACON Pharmaceuticals Inc
08/03/202323:40Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:TCONTRACON Pharmaceuticals Inc
08/03/202323:19Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:TCONTRACON Pharmaceuticals Inc
08/03/202323:16Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:TCONTRACON Pharmaceuticals Inc
08/03/202322:58Edgar (US Regulatory)Annual Report (10-k)NASDAQ:TCONTRACON Pharmaceuticals Inc
14/02/202318:58Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:TCONTRACON Pharmaceuticals Inc
13/02/202323:11Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:TCONTRACON Pharmaceuticals Inc
10/01/202314:30GlobeNewswire Inc.Runway Growth Finance Corp. Provides Fourth Quarter 2022 Portfolio UpdateNASDAQ:TCONTRACON Pharmaceuticals Inc
22/11/202215:35TipRanksTRACON Pharmaceuticals (TCON) Receives a Buy from Maxim GroupNASDAQ:TCONTRACON Pharmaceuticals Inc
21/11/202216:05TipRanksH.C. Wainwright Sticks to Its Buy Rating for TRACON Pharmaceuticals (TCON)NASDAQ:TCONTRACON Pharmaceuticals Inc
16/11/202220:25TipRanksMaxim Group Remains a Buy on TRACON Pharmaceuticals (TCON)NASDAQ:TCONTRACON Pharmaceuticals Inc
15/11/202223:05TipRanksJonesTrading Sticks to Its Buy Rating for TRACON Pharmaceuticals (TCON)NASDAQ:TCONTRACON Pharmaceuticals Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:TCON

La tua Cronologia

BIT
ISP
Intesa Sanpaolo
BIT
UCG
Unicredit
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
STLAM
Stellantis NV
BIT
BPE
Bper Banca
BIT
ENEL
Enel
BIT
TIT
Telecom Italia
BIT
PRY
Prysmian
BIT
SPM
Saipem
BIT
ENI
Eni
BIT
STMMI
ST Microelectronics
BIT
RACE
Ferrari NV
BIT
DLG
De Longhi
BIT
LDO
Leonardo
BIT
BAMI
Banco BPM
BIT
CPR
Davide Campari
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network